Literature DB >> 9830243

Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders.

T R Kwapil1.   

Abstract

College undergraduates (n = 34) identified by deviant scores (at least 1.96 SD above the mean) on the Revised Social Anhedonia (SocAnh) Scale (M. Eckblad, L. J. Chapman, J. P. Chapman, & M. Mishlove, 1982) were compared with control participants (n = 139) at an initial assessment and at a 10-year follow-up evaluation. Twenty-four percent of the SocAnh group were diagnosed with schizophrenia-spectrum disorders at the follow-up compared with only 1% of the control group, despite the fact that there had been no such difference between the groups at the initial assessment 10 years earlier. The SocAnh group exceeded the control group on severity of psychotic-like experiences and had poorer overall adjustment at the follow-up but not at the initial assessment. The groups did not differ on mood symptoms or substance-use disorders. Thus, the SocAnh Scale, unlike the Perceptual Aberration and Magical Ideation Scales, appears to identify individuals at specific risk for future development of schizophrenia-spectrum disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9830243     DOI: 10.1037//0021-843x.107.4.558

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  107 in total

1.  Schizotypal, schizoid and paranoid characteristics in the biological parents of social anhedonics.

Authors:  Alex S Cohen; Lindsay C Emmerson; Monica C Mann; Courtney B Forbes; Jack J Blanchard
Journal:  Psychiatry Res       Date:  2010-05-08       Impact factor: 3.222

2.  The challenges of fitting an item response theory model to the Social Anhedonia Scale.

Authors:  Steven P Reise; William P Horan; Jack J Blanchard
Journal:  J Pers Assess       Date:  2011-05

Review 3.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

4.  Social Disconnection in Schizophrenia and the General Community.

Authors:  Michael F Green; William P Horan; Junghee Lee; Amanda McCleery; L Felice Reddy; Jonathan K Wynn
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

5.  Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study.

Authors:  Matcheri S Keshavan; Vaibhav A Diwadkar; Debra M Montrose; Jeff A Stanley; Jay W Pettegrew
Journal:  World Psychiatry       Date:  2004-10       Impact factor: 49.548

6.  Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis.

Authors:  Minji Bang; Jee In Kang; Se Joo Kim; Jin Young Park; Kyung Ran Kim; Su Young Lee; Kyungmee Park; Eun Lee; Seung-Koo Lee; Suk Kyoon An
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

7.  Associations between trait anhedonia and emotional memory deficits in females with schizophrenia versus major depression.

Authors:  Emily K Olsen; Olivia A Bjorkquist; Anjuli S Bodapati; Stewart A Shankman; Ellen S Herbener
Journal:  Psychiatry Res       Date:  2015-09-09       Impact factor: 3.222

8.  Association between reduced extraversion and right posterior fusiform gyrus gray matter reduction in chronic schizophrenia.

Authors:  Toshiaki Onitsuka; Paul G Nestor; Ronald J Gurrera; Martha E Shenton; Kiyoto Kasai; Melissa Frumin; Margaret A Niznikiewicz; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

9.  Is the Divide a Chasm?: Bridging Affective Science with Clinical Practice.

Authors:  Lauren M Bylsma; Iris B Mauss; Jonathan Rottenberg
Journal:  J Psychopathol Behav Assess       Date:  2015-11-02

Review 10.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.